View in EDS HTML Full Text PDF Full Text

Type 2 diabetes, sodium-glucose cotransporter-2 inhibitors and cardiovascular outcomes: real world evidence versus a randomised clinical trial.

Saved in:
Bibliographic Details
Title: Type 2 diabetes, sodium-glucose cotransporter-2 inhibitors and cardiovascular outcomes: real world evidence versus a randomised clinical trial.
Authors: Yazdanfard, Puriya Daniel Würtz1,2 (AUTHOR) puriya.daniel.wuertz.yazdanfard@regionh.dk, Sørensen, Kathrine Kold1,2 (AUTHOR), Zareini, Bochra1 (AUTHOR), Pedersen-Bjergaard, Ulrik3,4 (AUTHOR), Ohlendorff, Johan Sebastian5 (AUTHOR), Munch, Anders5 (AUTHOR), Andersen, Mikkel Porsborg1,2,6 (AUTHOR), Hasselbalch, Rasmus Bo7 (AUTHOR), Imberg, Henrik8 (AUTHOR), Tasseleus, Viktor9 (AUTHOR), Lind, Marcus8 (AUTHOR), Valabhji, Jonathan10 (AUTHOR), Choudhary, Pratik11 (AUTHOR), Khunti, Kamlesh11 (AUTHOR), Schmid, Stefanie12,13 (AUTHOR), Lanzinger, Stefanie12,13 (AUTHOR), Mader, Julia14 (AUTHOR), Gerds, Thomas Alexander5 (AUTHOR), Torp-Pedersen, Christian1,2,5 (AUTHOR)
Source: Cardiovascular Diabetology. 9/30/2025, Vol. 24 Issue 1, p1-12. 12p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:14752840
DOI:10.1186/s12933-025-02924-0